| Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors A Astolfi, T Felicetti, N Iraci, G Manfroni, S Massari, D Pietrella, O Tabarrini, ... Journal of medicinal chemistry 60 (4), 1598-1604, 2017 | 68 | 2017 |
| 2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction T Felicetti, R Cannalire, D Pietrella, G Latacz, A Lubelska, G Manfroni, ... Journal of medicinal chemistry 61 (17), 7827-7848, 2018 | 49 | 2018 |
| Investigation on the effect of known potent S. aureus NorA efflux pump inhibitors on the staphylococcal biofilm formation S Sabatini, M Piccioni, T Felicetti, S De Marco, G Manfroni, R Pagiotti, ... RSC advances 7 (59), 37007-37014, 2017 | 37 | 2017 |
| Searching for Novel Inhibitors of the S. aureus NorA Efflux Pump: Synthesis and Biological Evaluation of the 3‐Phenyl‐1,4‐benzothiazine Analogues T Felicetti, R Cannalire, MS Burali, S Massari, G Manfroni, ML Barreca, ... ChemMedChem 12 (16), 1293-1302, 2017 | 35 | 2017 |
| Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium R Cannalire, D Machado, T Felicetti, SS Costa, S Massari, G Manfroni, ... European Journal of Medicinal Chemistry 140, 321-330, 2017 | 32 | 2017 |
| Modulating microRNA processing: enoxacin, the progenitor of a new class of drugs T Felicetti, V Cecchetti, G Manfroni Journal of Medicinal Chemistry 63 (21), 12275-12289, 2020 | 26 | 2020 |
| Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions R Cannalire, D Tarantino, G Piorkowski, T Carletti, S Massari, T Felicetti, ... Antiviral Research 167, 6-12, 2019 | 24 | 2019 |
| Deciphering the Molecular Recognition Mechanism of Multidrug Resistance Staphylococcus aureus NorA Efflux Pump Using a Supervised Molecular Dynamics … D Palazzotti, M Bissaro, G Bolcato, A Astolfi, T Felicetti, S Sabatini, ... International journal of molecular sciences 20 (16), 4041, 2019 | 23 | 2019 |
| Broad‐spectrum flavivirus inhibitors: a medicinal chemistry point of view T Felicetti, G Manfroni, V Cecchetti, R Cannalire ChemMedChem 15 (24), 2391-2419, 2020 | 22 | 2020 |
| From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors S Massari, A Corona, S Distinto, J Desantis, A Caredda, S Sabatini, ... Journal of Enzyme Inhibition and Medicinal Chemistry 34 (1), 55-74, 2019 | 22 | 2019 |
| Synthesis and characterization of 1, 2, 4-triazolo [1, 5-a] pyrimidine-2-carboxamide-based compounds targeting the PA-PB1 interface of influenza A virus polymerase S Massari, C Bertagnin, MC Pismataro, A Donnadio, G Nannetti, ... European journal of medicinal chemistry 209, 112944, 2021 | 21 | 2021 |
| Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position T Felicetti, R Cannalire, MG Nizi, O Tabarrini, S Massari, ML Barreca, ... European Journal of Medicinal Chemistry 155, 428-433, 2018 | 21 | 2018 |
| Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation A Astolfi, M Kudolo, J Brea, G Manni, G Manfroni, D Palazzotti, S Sabatini, ... European Journal of Medicinal Chemistry 182, 111624, 2019 | 20 | 2019 |
| 1, 2, 4-Triazolo [1, 5-a] pyrimidines: Efficient one-step synthesis and functionalization as influenza polymerase PA-PB1 interaction disruptors MC Pismataro, T Felicetti, C Bertagnin, MG Nizi, A Bonomini, ML Barreca, ... European Journal of Medicinal Chemistry 221, 113494, 2021 | 19 | 2021 |
| Microbial efflux pump inhibitors: A journey around quinoline and indole derivatives G Cernicchi, T Felicetti, S Sabatini Molecules 26 (22), 6996, 2021 | 17 | 2021 |
| Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors MG Nizi, J Desantis, Y Nakatani, S Massari, MA Mazzarella, G Shetye, ... European Journal of Medicinal Chemistry 201, 112420, 2020 | 16 | 2020 |
| C-2 phenyl replacements to obtain potent quinoline-based Staphylococcus aureus NorA inhibitors T Felicetti, G Mangiaterra, R Cannalire, N Cedraro, D Pietrella, A Astolfi, ... Journal of Enzyme Inhibition and Medicinal Chemistry 35 (1), 584-597, 2020 | 14 | 2020 |
| Modifications on C6 and C7 positions of 3-phenylquinolone efflux pump inhibitors led to potent and safe antimycobacterial treatment adjuvants T Felicetti, D Machado, R Cannalire, A Astolfi, S Massari, O Tabarrini, ... ACS Infectious Diseases 5 (6), 982-1000, 2019 | 12 | 2019 |
| Discovery of 2-phenylquinolines with broad-spectrum anti-coronavirus activity MG Nizi, L Persoons, A Corona, T Felicetti, G Cernicchi, S Massari, ... ACS Medicinal Chemistry Letters 13 (5), 855-864, 2022 | 11 | 2022 |
| From Quinoline to Quinazoline‐Based S. aureus NorA Efflux Pump Inhibitors by Coupling a Focused Scaffold Hopping Approach and a Pharmacophore Search N Cedraro, R Cannalire, A Astolfi, G Mangiaterra, T Felicetti, S Vaiasicca, ... ChemMedChem 16 (19), 3044-3059, 2021 | 8 | 2021 |
